-
Signature
-
/s/ Andrew Schiesl, as Attorney-in-Fact
-
Issuer symbol
-
IR
-
Transactions as of
-
18 Feb 2026
-
Net transactions value
-
-$80,451
-
Form type
-
4
-
Filing time
-
20 Feb 2026, 18:00:09 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Reynal Vicente |
Title: Chairman, President and Chief Executive Officer, Director |
C/O INGERSOLL RAND INC., 525 HARBOUR PLACE DRIVE, SUITE 600, DAVIDSON |
/s/ Andrew Schiesl, as Attorney-in-Fact |
20 Feb 2026 |
0001705738 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
IR |
Common Stock |
Options Exercise |
$9,549 |
+900 |
+0.47% |
$10.61 |
194,086 |
18 Feb 2026 |
Direct |
|
| transaction |
IR |
Common Stock |
Sale |
$90,000 |
-900 |
-0.46% |
$100.00 |
193,186 |
18 Feb 2026 |
Direct |
F1 |
| holding |
IR |
Common Stock |
|
|
|
|
|
147,802 |
18 Feb 2026 |
See footnote |
F2 |
| holding |
IR |
Common Stock |
|
|
|
|
|
75,000 |
18 Feb 2026 |
See footnote |
F3 |
| holding |
IR |
Common Stock |
|
|
|
|
|
22,500 |
18 Feb 2026 |
See footnote |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
IR |
Stock Options (Right to Buy) |
Options Exercise |
$0 |
-900 |
-0.6% |
$0.000000 |
148,536 |
18 Feb 2026 |
Common Stock |
900 |
$10.61 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
Remarks:
Title: Chairman, President and Chief Executive Officer